Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma

Clinical trial NCT03904563 · COMPLETED

Trial details

NCT number: NCT03904563
Sponsor: Sun Yat-sen University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Adenocarcinoma

Start date: 2019-01-01
Primary completion: 2021-12-10
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.